Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform-level update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.6.3 is now shown, replacing v3.6.0. This reflects a backend update to the site rather than changes to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label; recruitment status now states 'No longer looking for participants', and the page revision is updated to v3.6.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated the page version from v3.5.4 to v3.5.5. This reflects a small update to the page without changing the study details or other visible content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, replacing the previous version indicator. This reflects a minor update to the page's version history without altering visible content.SummaryDifference0.0%

- Check105 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the underlying clinical trial information.SummaryDifference0.0%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.